FDA Device Decisions, June 2026: A Blood Test for Esophageal Varices, Six Original PMAs and One De Novo Grant
One of the six original PMAs FDA approved in June 2026 is the HepQuant SHUNT Liver Diagnostic Test (P220016), a blood-based test that identifies patients with compensated cirrhosis who are unlikely to have large esophageal varices, and so unlikely to need an upper endoscopy at the time of testing. The Summary of Safety and Effectiveness Data (SSED) that FDA published with the approval states that no other in vitro diagnostic device can identify patients unlikely to have large esophageal varices.
June brought six original PMAs and one De Novo grant.
Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 324 510(k)s in June 2026, granted 1 De Novo request and approved 6 original PMAs. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.
Counts by pathway
June 2026 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.
| Pathway | June 2026 | May 2026 | June 2025 |
|---|---|---|---|
| 510(k) | 324 | 277 | 291 |
| De Novo | 1 | 4 | 3 |
| PMA (original) | 6 | 5 | 3 |
| PMA supplement | 179 | 208 | 216 |
Records held in RA Craft Database, decisions through August 31, 2026.
510(k) clearances were 47 more than in May and above June 2025 (291). De Novo grants fell from 4 in May to 1, and there were 6 original PMAs.
The busiest product codes
June's 510(k)s spread across 199 product codes. QIH (automated radiological image processing software) led with 11, followed by GEI (electrosurgical, cutting & coagulation & accessories) with 9, HGX (pump, breast, powered) with 8, and ITI (wheelchair, powered) and NHA (abutment, implant, dental, endosseous) with 6 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.
De Novo: software that reads ventilator waveforms
June's single De Novo grant, Class II, with the classification name and regulation number from its Classification Order:
- Syncron-E (DEN250025, Autonomous Healthcare, Inc.): Ventilator waveform analysis software (21 CFR 868.5896)
"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.
It is an adjunctive aid for detecting evidence of ineffective efforts during exhalation and rest periods in previously recorded mechanical ventilation waveforms, for adults 22 and older on invasive ventilation in volume control, pressure control or pressure support modes.
Original PMAs: six approvals
- AbsorbaSeal 5.6.7F Vascular Closure Device (P230038, Cyndrx, LLC): a bioabsorbable device that closes the femoral artery access site after catheterization (product code MGB)
- saypha® ChiQ™ (P250021, Croma-Pharma GmbH): a hyaluronic acid filler with lidocaine for cheek augmentation and midface volume (LMH)
- VENTANA PTEN (SP218) RxDx Assay (P250031, Ventana Medical Systems, Inc.): an immunohistochemistry companion diagnostic that assesses PTEN loss in prostate cancer tissue to identify patients for capivasertib with abiraterone (SHF)
- HepQuant SHUNT® Liver Diagnostic Test (P220016, HepQuant, LLC): identifies patients with compensated cirrhosis unlikely to have large esophageal varices (SIO)
- LungFX™ (P240033, Lung Bioengineering, Inc.; listed on this site as Centralized Lung Evaluation System): centralized ex vivo perfusion and ventilation to re-assess donor lungs that could not be placed for transplantation (PHO)
- AMDS™ Hybrid Prosthesis (P250055, Artivion, Inc.): an uncovered stent placed during open repair of acute DeBakey type I aortic dissection with malperfusion (QSK)
June also brought 179 PMA supplements, which cover changes to already approved PMA devices among other things.
Three devices worth a closer read
1. HepQuant SHUNT® Liver Diagnostic Test (P220016, PMA). 13C-cholate is given intravenously and d4-cholate by mouth, and their clearance from the blood produces a Disease Severity Index (DSI). Samples are analyzed at HepQuant's laboratory. For adults 22 and older with compensated (Child-Pugh A) cirrhosis undergoing screening or surveillance for esophageal varices, a DSI below the validated threshold identifies patients unlikely to have large varices, and so unlikely to need an upper endoscopy at the time of testing.
2. AMDS™ Hybrid Prosthesis (P250055, PMA). For acute DeBakey type I aortic dissection with malperfusion, in patients undergoing open surgical repair within 14 days of diagnosis. According to the SSED, the single-arm multicenter PERSEVERE study enrolled 93 patients and met both co-primary endpoints against their performance goals. The device received Breakthrough Device designation in 2019. Conditions of approval include five-year follow-up of the study cohort and a new post-approval study of at least 135 patients followed to 10 years.
3. Syncron-E (DEN250025, De Novo). Software that helps detect ineffective inspiratory efforts in ventilator waveforms, and only in data already recorded. Its four special controls include labeling with the compatible ventilators, a summary of clinical performance, failure modes and a warning against overreliance on the device output.
Compare the three devices
Open P220016, P250055 and DEN250025, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.
Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles